Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT00600405
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or older;
* able to read, write, and speak English;
* able to use the NRS pain scale; and
* computed tomography diagnosed single lower ureteral calculus
Exclusion Criteria:
* allergy or sensitivity to the study drug (tamsulosin hydrochloride \[Flomax\]);
* sulfa/sulfonamide allergy;
* inability to provide informed consent;
* lithiasis of the ureteral intramural tract;
* acute or chronic renal failure;
* fever;
* presence of multiple ureteral stones;
* peptic ulcer disease;
* liver failure;
* concomitant treatment with alpha-lytic drugs, calcium antagonists, nitrates, or vardenafil (Levitra);
* pregnancy;
* breastfeeding; or
* a history of urinary surgery or endoscopic treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00600405
Study Brief:
Protocol Section:
NCT00600405